GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Stereotaxis Inc.
Stereotaxis produces robotic magnetic navigation systems for the treatment of cardiac arrhythmias. Its stock price reflects the slow adoption of its innovative, but expensive, technology in hospitals. The chart tells the story of the struggle to commercialize a breakthrough product.
Share prices of companies in the market segment - Specialized medical equipment
Stereotaxis (STXS) is a pioneer in robotic technologies for cardiac procedures; its systems use magnets to navigate catheters for the treatment of cardiac arrhythmias. We classify it as "Specialized Medical Equipment." The graph below shows the dynamics in the robotic surgery sector.
Broad Market Index - GURU.Markets
Stereotaxis is a company that has developed a robotic magnetic navigation system for minimally invasive cardiac procedures. Its unique technology makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Stereotaxis compares to it.
Change in the price of a company, segment, and market as a whole per day
STXS - Daily change in the company's share price Stereotaxis Inc.
The daily price change of Stereotaxis, a developer of robotic systems for cardiac surgery, reflects innovation in medical technology. Change_co measures the high volatility associated with the implementation of its technology. This metric is an important element for analyzing companies in the medical equipment sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Stereotaxis, Inc. is a manufacturer of robotic systems for cardiac surgery. This chart highlights the high volatility of the MedTech sector. Comparison with STXS, whose technology is niche, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Stereotaxis is a manufacturer of a robotic system for treating cardiac arrhythmia. The medical technology market is growing rapidly, but it is also highly competitive. The chart below shows the volatility in this sector, helping to assess how Stereotaxis shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Stereotaxis Inc.
For Stereotaxis, Inc., the year-over-year trend is a story of the adoption of its robotic system for treating cardiac arrhythmia. Its market capitalization growth over the past 12 months reflects the growing number of hospitals installing its magnetic navigation system, which enables more precise and safe cardiac procedures—its key advantage.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Stereotaxis, Inc. is a manufacturer of robotic systems for minimally invasive cardiac procedures. The chart shows how its innovative technology, growing adoption, and competition in the medical device sector are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stereotaxis, with its robotic system for treating arrhythmia, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of technology adoption by surgeons. The chart reflects how this disruptive technology is struggling to gain market share in the conservative but vast cardiology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Stereotaxis Inc.
The value of Stereotaxis, a manufacturer of robotic systems for cardiology, depends on the adoption of its technology. The monthly fluctuations on the chart reflect the growth in the number of installations of its systems in hospitals, a slow but key indicator of its long-term growth.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Stereotaxis revolutionized the treatment of cardiac arrhythmias by creating a robotic magnetic navigation system that allows doctors to perform procedures with high precision. The graph below shows the overall dynamics of the medical equipment sector, where Stereotaxis' innovations occupy a unique niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Stereotaxis, Inc. develops robotic systems for cardiac procedures. As a company in the high-tech medical equipment sector, its success depends on the adoption of its technology in hospitals. Share price performance is driven by sales cycles and product news, rather than general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Stereotaxis Inc.
Shares of Stereotaxis, a developer of robotic systems for cardiac surgery, reflect advances in medical robotics. Weekly price movements depend on news about sales of its systems to clinics and regulatory approvals. The chart below shows how short-term events in the medical technology sector affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
How unique is Stereotaxis's performance in the MedTech sector? This chart compares the weekly stock price movements of this cardiac surgery robot developer with the industry average. The analysis will reveal whether its movements are driven by unique sales and system deployment news, or whether it follows the general sentiment of medical startups.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Stereotaxis develops robotic systems for cardiac surgery. This chart compares its weekly performance to the market. It helps understand what's driving the stock: the general trend in medical technology or news about the implementation of its systems in leading clinics, which is key to its growth.
Market capitalization of the company, segment and market as a whole
STXS - Market capitalization of the company Stereotaxis Inc.
Stereotaxis, Inc.'s market capitalization is based on its robotic magnetic navigation system for treating cardiac arrhythmias. The company's valuation depends on the adoption of its technology in hospitals worldwide. The chart illustrates the long and difficult path to commercialization of innovative, yet expensive, medical equipment.
STXS - Share of the company's market capitalization Stereotaxis Inc. within the market segment - Specialized medical equipment
Stereotaxis, Inc. captures its market share by producing robotic magnetic navigation systems for minimally invasive cardiac procedures. Its market capitalization reflects its unique technology, which improves the precision and safety of surgeries.
Market capitalization of the market segment - Specialized medical equipment
This chart is a barometer of the robotic surgery market. Stereotaxis, with its unique magnetic navigation system for cardiology, is a pioneer in this niche. The dynamics on the chart reflect how the market values innovative technologies that improve the precision and safety of medical procedures.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market valuation of robotic cardiac surgery. Stereotaxis's market cap is based on its magnetic navigation system, which makes surgeries less invasive. The line shows how high-tech companies in medicine are competing for a share of the future of global healthcare.
Book value capitalization of the company, segment and market as a whole
STXS - Book value capitalization of the company Stereotaxis Inc.
This chart illustrates the technological foundation of Stereotaxis, Inc. Its assets include patents and manufactured robotic magnetic navigation systems for the treatment of cardiac arrhythmias. The chart's dynamics show how the company is investing in the development and advancement of its unique technology in cardiac surgery.
STXS - Share of the company's book capitalization Stereotaxis Inc. within the market segment - Specialized medical equipment
Stereotaxis's tangible assets are not massive factories, but rather R&D centers and production lines for its robotic magnetic navigation systems for cardiac surgery. The chart shows the company's share of this high-tech and highly specialized medical infrastructure.
Market segment balance sheet capitalization - Specialized medical equipment
Below you can see the overall book value of the medical equipment sector. Compared to this, Stereotaxis, with its robotic system for cardiac procedures, looks "light." Its value lies in its unique technology and patents, not in mass production, which contrasts with consumables manufacturers.
Book value of all companies included in the broad market index - GURU.Markets
Stereotaxis produces robotic magnetic navigation systems for cardiac surgery. The company's assets are not hospitals, but rather the manufacturing facilities and intellectual property used to create these complex devices. The balance of these assets is the cost of the "navigation bridge" for the surgeon, allowing them to operate with incredible precision in a real human heart.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Stereotaxis Inc.
Stereotaxis's balance sheet is made up of its cash and robotic surgery systems. Its market cap is a bet on hospitals adopting its technology en masse. The MvsBCap_Co chart shows how the market views the likelihood of this "breakthrough" relative to its current holdings.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Stereotaxis develops robotic systems for minimally invasive cardiac procedures. Its value lies in its unique technology. The chart shows how the market values its innovations and potential to become a standard in electrophysiology, which translates into a premium for its tangible assets.
Market to book capitalization ratio for the market as a whole
Stereotaxis is a company that developed a robotic magnetic navigation system for minimally invasive cardiac procedures. Its value is determined by its unique technology and its clinical implementation. This chart helps explain why the medical technology sector often trades at a premium to its book value.
Debts of the company, segment and market as a whole
STXS - Company debts Stereotaxis Inc.
For Stereotaxis, a developer of robotic systems for treating cardiac arrhythmias, debt is a tool for innovation and commercialization. This chart shows how the company raises capital for R&D and promoting its unique technology to hospitals worldwide. In high-tech medicine, debt is an investment in the precision and safety of procedures.
Market segment debts - Specialized medical equipment
Stereotaxis develops robotic systems for minimally invasive cardiac procedures. Bringing complex medical equipment to market requires significant investment in R&D, clinical trials, and marketing. This chart shows how the company funds its innovations in robotic surgery.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Stereotaxis Inc.
Stereotaxis develops robotic systems for surgery. This chart shows the extent to which the company finances its innovation and market entry with debt. For a manufacturer of complex medical equipment requiring a long sales cycle and clinical implementation, a high debt load can become a risk if technology adoption is slow.
Market segment debt to market segment book capitalization - Specialized medical equipment
Stereotaxis is a pioneer in robotic systems for cardiac procedures. The company operates in a highly specialized niche of medical equipment. Innovation and market penetration require capital. The chart shows how the company's debt burden compares to the overall market capitalization of the high-tech medical equipment sector.
Debt to book value of all companies in the market
Stereotaxis (STXS) develops robotic systems for minimally invasive cardiac procedures. This high-tech medical equipment is used to develop innovative technologies. This chart shows the overall debt burden of the economy. It helps explain why companies like STXS often avoid debt during the technology implementation phase, relying on equity capital.
P/E of the company, segment and market as a whole
P/E - Stereotaxis Inc.
This chart for Stereotaxis, a developer of robotic systems for minimally invasive cardiac surgery, shows its valuation in the high-tech medical market. The price-to-earnings ratio is likely nonexistent. The company's value depends on its ability to sell and install its expensive systems in hospitals worldwide.
P/E of the market segment - Specialized medical equipment
This chart illustrates the average P/E for high-tech medical equipment manufacturers. For Stereotaxis, with its robotic system, it serves as a backdrop. It shows how highly investors value profitable companies, providing context for Stereotaxis's valuation, which is a bet on the future adoption of its innovative technology.
P/E of the market as a whole
Stereotaxis develops and manufactures robotic magnetic navigation systems for minimally invasive cardiac procedures, particularly for the treatment of arrhythmia. The company's technology improves surgical precision and safety. This risk appetite chart helps understand how investors evaluate innovations in medical robotics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Stereotaxis Inc.
Stereotaxis produces robotic magnetic navigation systems that enable physicians to perform highly accurate catheter-based procedures to treat cardiac arrhythmias. This graph shows expectations for the implementation of advanced technologies in cardiology. The estimate depends on sales of its systems to hospitals and the growth in the number of procedures performed using its innovative technology.
%20P%2FE%20Stereotaxis%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Stereotaxis-Inc.&v=1772588705107 "Chart of the company's future (projected) P/E Stereotaxis Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
Stereotaxis produces robotic magnetic navigation systems for minimally invasive cardiac procedures. This chart compares the company's future profitability expectations with those for the medical device sector. It reflects the market's belief that their cutting-edge technology will become the standard in electrophysiology and drive growth.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772588705271 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Stereotaxis produces robotic systems for navigating catheters for treating cardiac arrhythmias. Its business depends on the implementation of new technologies in hospitals. This market outlook influences Stereotaxis through healthcare budgets. Economic growth allows clinics to invest more in advanced equipment.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772588705358 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Stereotaxis Inc.
Stereotaxis produces robotic systems for catheter navigation in the treatment of cardiac arrhythmias. Its technology enables highly precise procedures. The company's profitability depends on the implementation of its robotic systems in hospitals worldwide. This chart shows the path of innovative medical equipment to widespread acceptance.
Profit of companies in the market segment - Specialized medical equipment
Stereotaxis develops robotic systems for minimally invasive cardiac surgeries. The implementation of such technologies in hospitals is a long process that determines financial performance. This chart reflects the dynamics of the high-tech medical equipment sector, where significant R&D and sales efforts precede growth and profitability.
Overall market profit
Stereotaxis develops robotic systems for minimally invasive cardiac surgeries. Implementing such advanced medical technologies is a long-term process, dependent on clinical benefits and hospital budgets. The company's growth is driven by innovation, not short-term economic cycles, as illustrated by this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Stereotaxis Inc.
Stereotaxis is a pioneer in robotic systems for minimally invasive cardiac procedures. This chart shows revenue expectations, which depend on the adoption of its technology by hospitals worldwide. Growing installed base and sales of consumables are key drivers for these forecasts.
%20profit%20of%20the%20company%20Stereotaxis%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Stereotaxis-Inc.&v=1772588705806 "Graph of future (projected) profit of the company Stereotaxis Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Stereotaxis produces robotic magnetic navigation systems for minimally invasive cardiac procedures. This chart shows the revenue forecast for the specialized medical equipment sector. It reflects expectations for the implementation of robotic technologies in surgery. This trend is the main driver for the increased use of Stereotaxis systems in hospitals.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772588705887 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Stereotaxis produces robotic systems for minimally invasive cardiac procedures. Demand for its expensive equipment depends on hospital capital budgets. The economic growth projected in this chart ensures the financial stability of healthcare systems and their ability to invest in advanced medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772588705961 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Stereotaxis Inc.
Stereotaxis develops and manufactures robotic magnetic navigation systems for minimally invasive cardiac procedures. This chart shows how investors estimate its revenue, which depends on the slow adoption of its cutting-edge but expensive technologies in hospitals and cardiac centers worldwide.
P/S market segment - Specialized medical equipment
Stereotaxis develops and manufactures robotic systems for navigating cardiac catheters during complex arrhythmia treatment procedures. Robotic Magnetic Navigation technology is designed to improve the precision and safety of procedures. This chart shows the average rating for the sector, helping to understand the market premium placed on Stereotaxis' innovative technology.
P/S of the market as a whole
Stereotaxis develops robotic systems for minimally invasive cardiac procedures, particularly for the treatment of arrhythmia. The company's technology uses magnetic navigation for precise catheter guidance. This chart compares the medical technology company's lofty revenue estimates with the more mundane figures of traditional companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Stereotaxis Inc.
Stereotaxis develops robotic systems for minimally invasive cardiac surgery. The company's future revenue depends on the adoption of its technologies in hospitals worldwide. This chart shows how investors assess the growth potential of the robotic surgery market and Stereotaxis' share of it.
%20P%2FS%20Stereotaxis%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Stereotaxis-Inc.&v=1772588706218 "The graph of the company's future (projected) P/S Stereotaxis Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
Stereotaxis develops and manufactures robotic systems for minimally invasive cardiac procedures, particularly for the treatment of arrhythmia. This chart compares the company's estimated future sales with those of other medical equipment manufacturers. It reflects investor expectations for the implementation of its robotic navigation system in clinics.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772588706331 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Stereotaxis produces robotic systems for catheter navigation in the treatment of cardiac arrhythmias. This is a high-tech medical market. The optimism reflected in this graph impacts hospital budgets. During periods of economic growth, they are more inclined to invest in expensive, innovative equipment, such as Stereotaxis systems.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772588706399 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Stereotaxis Inc.
Stereotaxis produces robotic magnetic navigation systems that help doctors perform complex cardiac procedures with high precision. The company's revenue comes from sales of its robotic systems and disposable instruments. The chart shows the level of adoption of this advanced medical technology by hospitals worldwide.
Sales of companies in the market segment - Specialized medical equipment
Stereotaxis is a company that produces robotic systems for catheter navigation in the treatment of cardiac arrhythmias. Its Genesis RMN technology uses magnets to precisely and safely guide instruments inside the heart. Revenue comes from sales of systems and disposable consumables. This chart shows the growth of the high-tech medical equipment market for cardiac surgery.
Overall market sales
Stereotaxis produces robotic systems for navigating catheters in the treatment of cardiac arrhythmias. Demand for its high-tech equipment depends on hospital budgets and their willingness to invest in innovation. This figure is important indirectly, as overall economic health affects the financial health of healthcare systems.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Stereotaxis Inc.
Stereotaxis develops robotic systems for catheter navigation in the treatment of cardiac arrhythmias. The company's growth depends on the implementation of its robotic technologies in hospitals and cardiology centers. This chart reflects analysts' expectations for an increase in the number of procedures performed using Stereotaxis systems, which is key to revenue growth.
%20sales%20of%20the%20company%20Stereotaxis%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Stereotaxis-Inc.&v=1772588706556 "Schedule of future (projected) sales of the company Stereotaxis Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Stereotaxis develops robotic systems for catheter navigation in the treatment of cardiac arrhythmias. This chart shows general expectations for the specialized medical equipment sector. Investors should evaluate how the technological advancement and adoption of robotic systems in cardiac surgery impact the growth potential of this niche medical company.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772588706597 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Stereotaxis, Inc. produces robotic systems for catheter navigation in the treatment of cardiac arrhythmias. This chart, reflecting hospital investments in high-tech equipment, is important to the company. Economic growth and stable healthcare funding allow hospitals to purchase advanced robotic systems to improve patient outcomes.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772588706746 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Stereotaxis Inc.
Stereotaxis is a pioneer in robotic surgery, creating systems for minimally invasive cardiac procedures. The company's business is the sale of high-tech medical equipment and consumables. This chart reflects the company's financial trajectory as it balances R&D with commercialization of its innovative robotic platforms.
Market segment marginality - Specialized medical equipment
Stereotaxis, Inc. has developed a robotic magnetic navigation system for complex cardiac procedures (ablation). This is high-tech medical equipment. This chart illustrates how the company balances high R&D and sales costs with revenue from selling its innovative systems to hospitals worldwide.
Market marginality as a whole
Stereotaxis produces a robotic magnetic navigation system for complex cardiac procedures. Overall profitability is less important to them. Their high margins are based on a unique, patented technology. Success depends on their ability to convince hospitals to invest in their expensive equipment by demonstrating its clinical benefits.
Employees in the company, segment and market as a whole
Number of employees in the company Stereotaxis Inc.
Stereotaxis is a pioneer in robotic systems for complex cardiac procedures. This graph shows the team of engineers and clinical specialists. The staffing dynamics reflect investments in the development of new-generation robots and efforts to expand their use in electrophysiology.
Share of the company's employees Stereotaxis Inc. within the market segment - Specialized medical equipment
Stereotaxis is a pioneer in robotic magnetic navigation for minimally invasive cardiac procedures. This chart shows the percentage of specialists the company attracts in the niche field of medical robotics. It's a testament to its technological leadership and the team that helps doctors perform the most complex cardiac surgeries.
Number of employees in the market segment - Specialized medical equipment
Stereotaxis develops robotic systems for catheter navigation in the treatment of cardiac arrhythmias. This chart shows employment in the high-tech medical equipment sector. The growth in the number of engineers and clinical specialists reflects the adoption of robotic technologies in interventional cardiology to improve the precision and safety of procedures.
Number of employees in the market as a whole
Stereotaxis, Inc. develops and manufactures robotic systems for minimally invasive cardiac surgeries. This is high-tech medical equipment. This graph shows the overall labor market, and companies like Stereotaxis represent the vanguard of the MedTech industry, where jobs are being created for engineers, physicians, and sales specialists in complex equipment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Stereotaxis Inc. (STXS)
Stereotaxis, Inc. develops robotic systems for cardiac procedures. It's a high-tech medical business, where value is determined by unique technology and patents. This chart shows a very high market capitalization per employee. A small team of engineers and clinicians is creating a product that could transform surgery, and the market is valuing precisely this potential.
%20of%20the%20company%20Stereotaxis%20Inc.%20(STXS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Stereotaxis-Inc.-STXS&v=1772588707506 "Chart of market capitalization per employee (in thousands of dollars) of the company Stereotaxis Inc. (STXS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Stereotaxis develops robotic systems for minimally invasive cardiac procedures. In the field of high-tech medical equipment, value is created through innovation. The graph shows the market premium placed on the company's intellectual property and technological leadership, assessing the contribution of each engineer and developer.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772588707527 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Stereotaxis develops robotic systems for catheter navigation in the treatment of cardiac arrhythmias. The company's value lies in its unique medical technology. This chart reflects its high market value per employee, demonstrating investors' confidence in the potential of their robotic platform to improve the precision and safety of complex cardiac procedures.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772588707588 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Stereotaxis Inc. (STXS)
Stereotaxis (STXS) produces robotic magnetic navigation systems for complex cardiac procedures (arrhythmia treatment). This is high-tech medical equipment. This graph shows how successfully the company is commercializing its niche technology. It measures how much revenue each employee (R&D engineer, clinical support specialist) generates.
%20Chart%20Stereotaxis%20Inc.%20(STXS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Stereotaxis-Inc.-STXS&v=1772588707718 "Company Profit Per Employee (in thousands of dollars) Chart Stereotaxis Inc. (STXS)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Stereotaxis produces the Genesis robotic system for catheter navigation in the treatment of cardiac arrhythmias. Their business is selling complex systems and consumables. This chart represents an industry benchmark. It helps evaluate how effectively the Stereotaxis team (engineers, salespeople) is monetizing their unique robotic platform.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772588707750 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Stereotaxis develops and manufactures robotic magnetic navigation systems for complex cardiac procedures (such as ablation). This is high-tech medical equipment. Revenue per employee depends on the company's ability to sell these expensive systems (a capital expense for hospitals) and, more importantly, on recurring revenue from the disposable instruments used in the procedures.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772588707804 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Stereotaxis Inc. (STXS)
Stereotaxis produces robotic systems for catheter navigation in the treatment of cardiac arrhythmias. This chart shows productivity in the high-tech medical equipment sector. The high revenue per employee is due to the high cost of the robotic systems sold to hospitals and cardiology centers.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Stereotaxis-Inc.-STXS&v=1772588707857 "Sales chart per company employee Stereotaxis Inc. (STXS)")
Sales per employee in the market segment - Specialized medical equipment
Stereotaxis (STXS) is a medical technology company that developed a robotic magnetic navigation system (Genesis) for minimally invasive cardiac surgeries. This graph shows the revenue (from sales of systems and consumables) generated by each employee. It is an indicator of the commercial success of their high-tech robotic platform.
Sales per employee for the market as a whole
Stereotaxis is a medical device manufacturer that created the Genesis RMN robotic navigation system. This system uses magnets to precisely guide catheters inside the heart. It's a high-tech R&D company. This chart shows how successfully the company sells these expensive robotic systems and their consumables through its specialized staff.
Short shares by company, segment and market as a whole
Shares shorted by company Stereotaxis Inc. (STXS)
Stereotaxis is a manufacturer of robotic magnetic navigation systems for complex cardiac procedures (arrhythmia treatment). This chart shows bearish bets. The shorts may be due to the company burning cash, and its technology, despite its innovation, is struggling to gain market share from more traditional methods.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Stereotaxis-Inc.-STXS&v=1772588708278 "Short Shares Chart for the Company Stereotaxis Inc. (STXS)")
Shares shorted by market segment - Specialized medical equipment
Stereotaxis (STXS) is a company that produces robotic magnetic navigation systems that help doctors perform complex heart surgeries (arrhythmia treatment). This chart shows the odds against the MedTech sector. The rising odds against the industry reflect concerns that hospitals will cut budgets for expensive capital equipment like Stereotaxis systems during the recession.
Shares shorted by the overall market
Stereotaxis (STXS) develops robotic systems for cardiac surgery. This high-tech medical equipment is a key component of the company's development. This market anxiety can impact STXS. During periods of panic, hospitals may freeze budgets for expensive new equipment, postponing contracts with STXS.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Stereotaxis Inc. (STXS)
Stereotaxis is a manufacturer of robotic magnetic navigation systems for complex cardiac surgeries (arrhythmia treatment). This chart measures how investors view this disruptive, yet niche, technology. It shows when the stock is overbought due to expectations of adoption or oversold due to slow sales.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Stereotaxis-Inc.-STXS&v=1772588708629 "RSI 14 indicator chart for the company's stock Stereotaxis Inc. (STXS)")
RSI 14 Market Segment - Specialized medical equipment
Stereotaxis is the developer of the Genesis RMN robotic magnetic navigation system. It allows doctors to precisely guide catheters for treating cardiac arrhythmias. This indicator reflects the overall momentum in the robotic surgery sector and helps determine whether the entire segment is overheated by expectations.
RSI 14 for the overall market
Stereotaxis, a developer of surgical robots, sees hospital budgets in this graph. During periods of euphoria and budget growth, clinics eagerly purchase innovative, expensive equipment. During moments of panic and cost-cutting, these multi-million dollar purchases are postponed indefinitely in favor of savings.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast STXS (Stereotaxis Inc.)
Stereotaxis is a pioneer in robotic navigation for cardiac procedures (arrhythmia treatment). Their Genesis system uses magnets to guide catheters. This chart shows the average analyst forecast. Their targets are based on sales of new robotic systems to hospitals and the growth in the number of procedures using them.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-STXS-Stereotaxis-Inc.&v=1772588709008 "A chart showing analyst consensus forecasts for the expected stock price. STXS (Stereotaxis Inc.)")
The difference between the consensus estimate and the actual stock price STXS (Stereotaxis Inc.)
Stereotaxis (STXS) is a medical technology company that developed the Genesis robotic navigation system, which uses magnets to precisely guide catheters for arrhythmia treatment. This chart shows the valuation of their robotics technology. It measures the gap between the price and the consensus target, reflecting analysts' confidence in their ability to implement this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-STXS-Stereotaxis-Inc.&v=1772588709099 "A chart showing the difference between the consensus forecast and the actual stock price. STXS (Stereotaxis Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Stereotaxis is the manufacturer of the Genesis robotic catheter navigation system. It uses magnets to precisely guide instruments used to treat cardiac arrhythmia. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the robotic cardiac surgery market will grow.
Analysts' consensus forecast for the overall market share price
Stereotaxis is a pioneer in robotic cardiac surgery. Their system (Genesis) uses magnets to navigate catheters for arrhythmia treatment. This chart shows the overall "risk appetite." For Stereotaxis, a company with high-tech and expensive equipment, overall market optimism is important because it reflects hospitals' willingness to invest in innovative medical technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Stereotaxis Inc.
Stereotaxis is magnetic guidance in surgery. They produce a unique robotic system (Genesis) that uses magnets for ultra-precise guidance of catheters inside the heart during arrhythmia treatments. This graph is an assessment of their unique, slow technology. It reflects their ability to sell these expensive systems to hospitals and their long struggle to achieve widespread adoption.
AKIMA Market Segment Index - Specialized medical equipment
Stereotaxis is a leader in robotic systems for treating cardiac arrhythmias. Their Magnetic Navigation technology allows doctors to perform complex procedures. This chart reflects the average index for the specialized medical equipment sector. It helps assess how Stereotaxis' innovative business model compares to the industry average.
The AKIM Index for the overall market
Stereotaxis is a pioneer in robotic magnetic navigation for arrhythmia treatment. This technology enables highly precise catheter guidance. This chart, reflecting the market average, is a backdrop. It helps assess how this innovative MedTech company, dependent on hospital capital expenditures, compares to overall macroeconomic trends.
